Results for tag: "Hypothyroidism Drug"

The Hypothyroidism Drug market is a segment of the Endocrine and Metabolic Disorders Drugs market. Hypothyroidism is a condition in which the thyroid gland does not produce enough of certain hormones, leading to a range of symptoms. Treatment for hypothyroidism typically involves taking a daily medication to replace the hormones the body is not producing. Common drugs used to treat hypothyroidism include levothyroxine, liothyronine, and liotrix. The Endocrine and Metabolic Disorders Drugs market is a large and growing market, driven by an aging population and increasing prevalence of chronic conditions. The market is expected to continue to grow in the coming years, driven by the development of new treatments and the increasing prevalence of endocrine and metabolic disorders. Companies in the Hypothyroidism Drug market include AbbVie, Mylan, Teva Pharmaceuticals, and Merck. Show Less Read more